Evidence abounds that inflammatory mononuclear phagocyte iMP; microglial cells, perivascular and brain macrophage) secretory processes are centrally implicated in the neuropathogenesis of HIV-1-associated dementia (HAD). Whether this can be harnessed to positively affect neurodegenerative processes is less apparent. Thus, this program project (PPG) seeks support for investigating the specific immunologic basis of HAD and linkages between it and other neurodegenerative disorders. The focal point of disordered immunity for HAD is the microglia, the cell that links all PPG research efforts. The studies will utilize, as its foundation, a well-developed research infrastructure within the Center for Neurovirology and Neurodegenerative Disorders (CNND) of the University of Nebraska Medical Center. The CNND consists of investigators of diverse expertise who maintain a unified focus for their research on how MP biology affects both neurodegeneration and neuroprotection. This group of scientists has significant expertise in areas of neurotoxicology, cellular immunology, neuropathology, neurophysiology, neuropharmacology and molecular biology. """"""""State of the art"""""""" technologies in magnetic resonance imaging/spectroscopy, electrophysiology, gene arrays and proteomics are being developed and strengthen this proposal. Currently, ties between innate and acquired immunity for brain MP function serve to bridge all of the proposed projects. It is our hypothesis that inflammatory mechanisms cause or intensify tissue damage during neurodegenerative processes. Most importantly, we believe these can be reversed through drug or immune manipulations. We purport that the interplay between the peripheral immune system and the brain serves to counter neuronal death caused as a result of viral infection. The balance between MP trophic and toxic activities may, therefore, underlie the process of dementia. The strength of this proposal is its well-developed cross-disciplinary program of young, energetic investigators whose scientific expertise spans the gantlet of MP-virus-neural interactions. Working under one roof, in one organizational structure with a strong track record of collaboration and joint publications should serve the PPG well in its quest to merge research initiatives designed to address pathogenic and therapeutic aspects of HAD. Results of these works should have implications for monitoring disease and in developing novel therapeutics (for example, Alzheimer's disease) which now has few treatment options.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS043985-04
Application #
7068635
Study Section
Special Emphasis Panel (ZNS1-SRB-A (02))
Program Officer
Nunn, Michael
Project Start
2003-05-15
Project End
2008-04-30
Budget Start
2006-05-01
Budget End
2007-04-30
Support Year
4
Fiscal Year
2006
Total Cost
$1,171,485
Indirect Cost
Name
University of Nebraska Medical Center
Department
Pathology
Type
Schools of Medicine
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Olson, Katherine E; Bade, Aditya N; Namminga, Krista L et al. (2018) Persistent EcoHIV infection induces nigral degeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice. J Neurovirol 24:398-410
Schutt, Charles R; Gendelman, Howard E; Mosley, R Lee (2018) Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease. Mol Neurodegener 13:26
Thomas, Midhun B; Gnanadhas, Divya Prakash; Dash, Prasanta K et al. (2018) Modulating cellular autophagy for controlled antiretroviral drug release. Nanomedicine (Lond) 13:2139-2154
Kiyota, Tomomi; Machhi, Jatin; Lu, Yaman et al. (2018) URMC-099 facilitates amyloid-? clearance in a murine model of Alzheimer's disease. J Neuroinflammation 15:137
Kevadiya, Bhavesh D; Woldstad, Christopher; Ottemann, Brendan M et al. (2018) Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution. Theranostics 8:256-276
McMillan, JoEllyn; Szlachetka, Adam; Slack, Lara et al. (2018) Pharmacokinetics of a Long-Acting Nanoformulated Dolutegravir Prodrug in Rhesus Macaques. Antimicrob Agents Chemother 62:
Sillman, Brady; Woldstad, Christopher; Mcmillan, Joellyn et al. (2018) Neuropathogenesis of human immunodeficiency virus infection. Handb Clin Neurol 152:21-40
Zhou, Tian; Su, Hang; Dash, Prasanta et al. (2018) Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles. Biomaterials 151:53-65
Kevadiya, Bhavesh D; Ottemann, Brendan M; Thomas, Midhun Ben et al. (2018) Neurotheranostics as personalized medicines. Adv Drug Deliv Rev :
Zhou, Tian; Lin, Zhiyi; Puligujja, Pavan et al. (2018) Optimizing the preparation and stability of decorated antiretroviral drug nanocrystals. Nanomedicine (Lond) 13:871-885

Showing the most recent 10 out of 240 publications